Reactivating the p53 Tumor Suppressor Gene
September 7, 2021 | Terry Sharrer
Cancer immunotherapy reactivates tumor suppressor protein
MAIN rarely covers drug discovery, which is a huge field in itself, but this piece from cancer researchers at the Karolinska Institute in Stockholm describes how reactivating p53 transforms the tumor microenvironment for immunotherapy. MORE
Image Credit: vitanovsky/Depositphotos and NewAtlas.com
=
